Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combizym and Bifidobacteria for Colon Polyp Recurrence
NCT02097394Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jun 2013
- Primary completion
- Jun 2020
- Modality
- Replacement Enzymes, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Aspergillus oryzae + Pancreatin, Bifidobacteria in colon polyp, sponsored by Renji Hospital. Status: unknown.
02
Drugs
Aspergillus oryzae + PancreatinBifidobacteria
03
Conditions
colon polyp
Beyond the preview
Go deeper on NCT02097394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097394.